BT
Beyang Therapeutics
China · Biotech · AI
AI-driven drug discovery company using its ExCEED molecular design platform
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $30M | China Medical System Holdings — Role not disclosedFenglei Capital — Role not disclosedHarbor & Canton Capital — Role not disclosedLegend Capital — Role not disclosedRoot Venture Partners — Role not disclosedShanghai Healthcare Capital — Role not disclosedShanghai Sci-Tech Innovation Center Capital — Role not disclosedYuanBio Venture Capital — Role not disclosed |